Vireo Growth Inc. (VREOF)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch VREOF
See up to 3 months of VREOF. The 7-day demo opens the 1M and 3M ranges and puts VREOF on your watchlist.
Start 7-day demoLatest VREOF insider trades
- Chicago Atlantic Group GP, LLC - 10% OwnerOpen-market purchase0 sh
Victor E. Mancebo - DirectorGrant or award115,506 sh- Victor E. Mancebo
About Vireo Growth Inc. (VREOF)
The SEC lists Vireo Growth Inc. under CIK 0001771706, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
VREOF Form 4 activity by transaction type, last 90 days
No Form 4 activity for VREOF in the last 90 days.
VREOF insider transactions (Form 4)
3114 Form 4 filings on record, the earliest from Oct 11, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Victor E. Mancebo - Director | Grant or award | Stock options (right to buy) | 115,506 | $0.00 | - | |
| Victor E. Mancebo - Director | Grant or award | Restricted stock units | 96,859 | $0.00 | - | |
| Victor E. Mancebo - Director | Grant or award | Stock options (right to buy) | 95,310 | $0.00 | - | |
| Victor E. Mancebo - Director | Grant or award | Restricted stock units | 80,000 | $0.00 | - | |
| Ross Michael Hussey - Director | Grant or award | Stock options (right to buy) | 115,506 | $0.00 | - | |
| Ross Michael Hussey - Director | Grant or award | Restricted stock units | 96,859 | $0.00 | - | |
| Ross Michael Hussey - Director | Grant or award | Stock options (right to buy) | 95,310 | $0.00 | - | |
| Ross Michael Hussey - Director | Grant or award | Restricted stock units | 80,000 | $0.00 | - | |
| Judd Theodore Nordquist - Director | Grant or award | Stock options (right to buy) | 115,506 | $0.00 | - | |
| Judd Theodore Nordquist - Director | Grant or award | Restricted stock units | 96,859 | $0.00 | - | |
| Judd Theodore Nordquist - Director | Grant or award | Stock options (right to buy) | 95,310 | $0.00 | - | |
| Judd Theodore Nordquist - Director | Grant or award | Restricted stock units | 80,000 | $0.00 | - | |
| Joseph Duxbury - Officer | Option exercise | Subordinate voting shares | 133,333 | - footnote F1 | - | |
| Joseph Duxbury - Officer | Tax withholding / forfeiture | Subordinate voting shares | 40,799 footnote F2 | $0.39 | $16K | |
| Joseph Duxbury - Officer | Grant or award | Restricted stock units | 133,333 | $0.00 | - | |
| Joseph Duxbury - Officer | Option exercise | Restricted stock units | 133,333 | $0.00 | - | |
| ||||||
| Sean Michael Apfelbaum - Officer | Option exercise | Subordinate voting shares | 133,333 | - footnote F1 | - | |
| Sean Michael Apfelbaum - Officer | Tax withholding / forfeiture | Subordinate voting shares | 39,067 footnote F2 | $0.39 | $15K | |
| Sean Michael Apfelbaum - Officer | Grant or award | Restricted stock units | 133,333 | $0.00 | - | |
| Sean Michael Apfelbaum - Officer | Option exercise | Restricted stock units | 133,333 | $0.00 | - | |
| ||||||
| Sean Michael Apfelbaum - Officer | Grant or award | Restricted stock units | 200,000 | $0.00 | - | |
| Joseph Duxbury - Officer | Grant or award | Restricted stock units | 360,000 | $0.00 | - | |
| Chicago Atlantic Group GP, LLC - 10% Owner | Other | Convertible Note (right to buy) | 0 | $10,000,000.00 | - | |
| Chicago Atlantic Group GP, LLC - 10% Owner | Open-market purchase | Convertible Note (right to buy) | 0 | $10,000,000.00 | - | |
| Tyson Macdonald - Officer | Grant or award | Subordinate Voting Shares | 3,200,000 | $0.00 | - | |
| Kyle Eugene Kingsley - Officer | Grant or award | Subordinate Voting Shares | 7,000,000 | $0.00 | - | |
| John Mazarakis - Officer | Grant or award | Subordinate Voting Shares | 3,200,000 | $0.00 | - | |
| Amber Holly Shimpa - Officer | Grant or award | Stock Option (right to buy) | 1,000,000 | $0.00 | - | |
| Joshua Rosen - Officer | Grant or award | Subordinate Voting Shares | 500,000 | $0.00 | - | |
| Joshua Rosen - Officer | Grant or award | Stock Option (right to buy) | 250,000 | $0.00 | - | |
| Joshua Rosen - Officer | Grant or award | Stock Option (right to buy) | 500,000 | $0.00 | - | |
Item 1.01, 1.02, 2.03, 7.01, 9.01
Item 2.01, 3.02, 7.01, 9.01
Item 7.01, 8.01, 9.01
Item 1.01, 2.01, 2.03, 3.02, 7.01, 9.01
VREOF insider trading FAQ
What is the latest insider trade for VREOF?
Vireo Growth Inc. (VREOF) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-19. The full record for VREOF runs to 14 Form 4 filings, the earliest from 2024-10-11. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VREOF stock?
No insider purchases of VREOF were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling VREOF stock?
No insider sales of VREOF were filed in the last 90 days.
Where can I see VREOF SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VREOF Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Victor E. Mancebo view on EDGAR
- - Ross Michael Hussey view on EDGAR
- - Judd Theodore Nordquist view on EDGAR
- - Joseph Duxbury view on EDGAR
- - Sean Michael Apfelbaum view on EDGAR
- - Sean Michael Apfelbaum view on EDGAR
- - Joseph Duxbury view on EDGAR
- - Chicago Atlantic Group GP, LLC view on EDGAR
- - Tyson Macdonald view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where VREOF's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VREOF with a 7-day demo
- VREOF on your watchlist
- Every VREOF Form 4 filing on record
- Up to 3 months of VREOF price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
